NEUROCRINE INC has a total of 11 patent applications. Its first patent ever was published in 2002. It filed its patents most often in Argentina, Australia and Brazil. Its main competitors in its focus markets organic fine chemistry and pharmaceuticals are ASCEPION PHARMACEUTICALS INC, DUBOIS LAURENT and SGX PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Argentina | 1 | |
#2 | Australia | 1 | |
#3 | Brazil | 1 | |
#4 | China | 1 | |
#5 | Colombia | 1 | |
#6 | Czechia | 1 | |
#7 | Hungary | 1 | |
#8 | Israel | 1 | |
#9 | New Zealand | 1 | |
#10 | United States | 1 | |
#11 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Gentile Gabriella | 9 |
#2 | St-Denis Yves | 7 |
#3 | Haddach Mustapha | 7 |
#4 | Di Fabio Romano | 6 |
#5 | Williams John Patrick | 6 |
#6 | Fabio Romano Di | 2 |
#7 | St Denis Yves | 1 |
#8 | Mustapha Haddach | 1 |
#9 | Difabio Romano | 1 |
#10 | Williams Joh Patrick | 1 |
Publication | Filing date | Title |
---|---|---|
IL158806D0 | Tri-and tetraaza-acenaphthylen derivatives as crf receptor antagonists |